AKEBIA THERAPEUTICS INC's ticker is AKBA and the CUSIP is 00972D105. A total of 126 filers reported holding AKEBIA THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 1.48 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $293,000 | -24.9% | 102,100 | 0.0% | 0.00% | 0.0% |
Q2 2021 | $390,000 | +23.0% | 102,100 | 0.0% | 0.00% | 0.0% |
Q1 2021 | $317,000 | +13.6% | 102,100 | 0.0% | 0.00% | 0.0% |
Q4 2020 | $279,000 | +16.7% | 102,100 | 0.0% | 0.00% | 0.0% |
Q3 2020 | $239,000 | -60.6% | 102,100 | -30.6% | 0.00% | -75.0% |
Q3 2019 | $606,000 | -59.6% | 147,100 | -54.6% | 0.00% | -50.0% |
Q2 2019 | $1,501,000 | +782.9% | 324,200 | +1473.8% | 0.01% | +700.0% |
Q1 2019 | $170,000 | +78.9% | 20,600 | +20.5% | 0.00% | 0.0% |
Q4 2018 | $95,000 | -44.1% | 17,100 | -17.0% | 0.00% | 0.0% |
Q3 2018 | $170,000 | -11.9% | 20,600 | 0.0% | 0.00% | 0.0% |
Q2 2018 | $193,000 | -4.0% | 20,600 | 0.0% | 0.00% | 0.0% |
Q1 2018 | $201,000 | +32.2% | 20,600 | +21.2% | 0.00% | -50.0% |
Q1 2016 | $152,000 | -18.7% | 17,000 | +15.6% | 0.00% | 0.0% |
Q4 2015 | $187,000 | +33.6% | 14,700 | +1.4% | 0.00% | 0.0% |
Q3 2015 | $140,000 | +0.7% | 14,500 | +7.4% | 0.00% | 0.0% |
Q2 2015 | $139,000 | +31.1% | 13,500 | +42.1% | 0.00% | +100.0% |
Q1 2015 | $106,000 | – | 9,500 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Alerce Investment Management, L.P. | 4,652,561 | $3,340,000 | 5.66% |
Orchard Capital Management, LLC | 1,762,731 | $1,265,000 | 0.36% |
Ikarian Capital, LLC | 1,200,000 | $860,000 | 0.11% |
Ikarian Capital, LLC | 800,000 | $575,000 | 0.08% |
XTX Topco Ltd | 102,392 | $74,000 | 0.03% |
Nantahala Capital Management | 965,800 | $693,000 | 0.03% |
Worth Venture Partners, LLC | 63,500 | $46,000 | 0.02% |
Ardent Capital Management, Inc. | 43,429 | $31,000 | 0.02% |
Virtus ETF Advisers LLC | 65,149 | $47,000 | 0.02% |
RICE HALL JAMES & ASSOCIATES, LLC | 513,292 | $368,000 | 0.02% |